Article info
PDFIschemic stroke
Original research
Real-world outcomes associated with the use of the EmboTrap revascularization device for ischemic stroke in the United States
- Correspondence to Dr Rahul Khanna, Medical Device Epidemiology and Real-World Data Sciences, Johnson and Johnson, New Brunswick, New Jersey, 08901, USA; rkhann14{at}its.jnj.com
Citation
Real-world outcomes associated with the use of the EmboTrap revascularization device for ischemic stroke in the United States
Publication history
- Received August 23, 2021
- Accepted October 20, 2021
- First published November 8, 2021.
Online issue publication
October 14, 2022
Article Versions
- Previous version (8 November 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.